ORM-12741 clinical trials
Also written ORM-12741.
- studies test it
- 12
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses ORM-12741 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2009 (4)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 11 · Other 1
Orion Corporation, Orion Pharma (11) · University of Cape Town (1)
Often tested with
Tested in the same studies.
ORM-14540 (1)
Studies
Open first, then newest update. How each study uses ORM-12741 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 12
- Safety and Efficacy of ORM-12741 in Patients With Alzheimer's DiseaseCompletedPhase 2Orion Corporation, Orion PharmaNCT01324518Written as ORM-12741How we know
- Single-dose Novel Selective alpha2c Antagonist Pharmaco-MRI Study in Healthy VolunteersCompletedPhase 1University of Cape TownNCT03440021Written as ORM-12741How we know
- Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's DiseaseCompletedPhase 2Orion Corporation, Orion PharmaNCT02471196Written as ORM-12741How we know
- Pharmacokinetic Study of Multiple Doses of ORM-12741 (Nebula PK 2)CompletedPhase 1Orion Corporation, Orion PharmaNCT02303860Written as ORM-12741 MR AHow we know
- Pharmacokinetic Study of Single Doses of ORM-12741CompletedPhase 1Orion Corporation, Orion PharmaNCT02319057Written as ORM-12741 MR AHow we know
- Safety and Pharmacokinetic Study With Multiple Ascending Doses of ORM-12741CompletedPhase 1Orion Corporation, Orion PharmaNCT01068028Written as ORM-12741How we know
- Safety and Tolerability Study With Single Ascending Doses of ORM-12741CompletedPhase 1Orion Corporation, Orion PharmaNCT00693316Written as ORM-12741How we know
- A PET Study With ORM-12741CompletedPhase 1Orion Corporation, Orion PharmaNCT00829907Written as ORM-12741How we know
- Pharmacokinetic Study of ORM-12741 in Healthy VolunteersCompletedPhase 1Orion Corporation, Orion PharmaNCT00818740Written as ORM-12741How we know
- Early Phase I Microdosing Study of ORM-14540 and ORM-12741CompletedEarly Phase 1Orion Corporation, Orion PharmaNCT00831077Written as ORM-12741How we know
- Safety and Tolerability Study With Multiple Ascending Doses of ORM-12741CompletedPhase 1Orion Corporation, Orion PharmaNCT00792493Written as ORM-12741How we know
- Excretion Balance and Metabolism After a Single Oral Dose of 14C-Labelled ORM-12741CompletedPhase 1Orion Corporation, Orion PharmaNCT00817544Written as ORM-12741How we know
Codes
What other systems call ORM-12741 · ClinicalTrials.gg INT000014
- Wikidata Q27276003orm-12741One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27276003 | orm-12741 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.